Acceptability and Tolerance Study of a Low Calorie Peptide Based Paediatric Tube Feed Formula.
NCT03718208 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2020-08-19
Summary
This is an acceptability study to evaluate the gastrointestinal tolerance and compliance over a seven-day period, of a low calorie paediatric peptide based tube feed formula for the dietary management of participants with short bowel syndrome; intractable malabsorption; preoperative preparation of undernourished patients; inflammatory bowel disease; total gastrectomy; dysphagia; bowel fistulae;
The acceptability data from 15 participants will be collected in order to submit an application to the Advisory Committee on Borderline Substances (ACBS).
Conditions
- Cerebral Palsy
Interventions
- DIETARY_SUPPLEMENT
-
Paediatric Formula
Children will switch over to the low calorie paediatric feed. Intake diaries and tolerance diaries will be completed for one week.
Sponsors & Collaborators
-
Société des Produits Nestlé (SPN)
lead INDUSTRY
Principal Investigators
-
Clare Thornton-Wood, BSc · Dietitian
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Year
- Max Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-08
- Primary Completion
- 2019-07-22
- Completion
- 2019-07-22
Countries
- United Kingdom
Study Locations
More Related Trials
-
Acceptability, Gastrointestinal Tolerance, Compliance and Palatability Study.
NCT07210658 ·Status: RECRUITING ·Phase: NA
-
Retrospective Tube Feeding Tolerance in Adults With Intolerance After Switch to a Peptide-Based Formula
NCT03048409 ·Status: COMPLETED
-
Feeding Trial in Pediatric Patients
NCT01469117 ·Status: COMPLETED
-
Enteral Formula Tolerance of Standard Tube Feedings
NCT02312271 ·Status: COMPLETED
-
Growth and Tolerance of Plant-based Enteral Formulas in Children Ages 12-17 Months.
NCT07231705 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediatric Population
NCT01191112 ·Status: COMPLETED ·Phase: PHASE3
-
Enteral Formula Tolerance in Pediatric Patients
NCT02779335 ·Status: COMPLETED ·Phase: NA
-
Feeding Intolerance in Formula-Fed Infants
NCT02028156 ·Status: TERMINATED ·Phase: NA
-
Tolerance of Healthy Infants Fed Infant Formulas
NCT02401217 ·Status: COMPLETED ·Phase: NA
-
Gastrointestinal Tolerance Evaluation of an Infant Formula
NCT03307122 ·Status: COMPLETED ·Phase: NA
-
Effects of Specific Lipid Fractions-enriched Infant Formulae
NCT02111837 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA.
NCT06481280 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Chewing Capability Study for Infants and Toddlers
NCT02156986 ·Status: COMPLETED
-
Acceptability and Tolerance Study of an Amino Acid Formula with HMOs
NCT04575298 ·Status: TERMINATED
-
Digestive Tolerance of Slightly Hydrolyzed Starter Infant Formula With Probiotics
NCT01036243 ·Status: COMPLETED ·Phase: NA
-
Study in Unsettled Infants Experiencing Feeding Intolerance
NCT02021058 ·Status: COMPLETED ·Phase: NA
-
Tolerance of an Extensively Hydrolyzed Protein Infant Formula Versus a Premature Infant Formula
NCT01987154 ·Status: COMPLETED ·Phase: NA
-
Feeding Infant Formula With Added Probiotics and Whey Protein Concentrate
NCT01755481 ·Status: COMPLETED ·Phase: NA
-
An Infant Formula Trial on Dietary Management of Infantile Colic
NCT03329222 ·Status: TERMINATED ·Phase: NA
-
Tolerance of Healthy Term Infants Fed Infant Formulas #3
NCT00977964 ·Status: COMPLETED ·Phase: PHASE3
-
Acceptability and Gastrointestinal Tolerance of a High-Sn-2 Infant Formula
NCT02598817 ·Status: COMPLETED
-
Growth of Healthy Term Infants Fed a Partially Hydrolyzed Follow-up Formula
NCT03276663 ·Status: COMPLETED ·Phase: NA
-
Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants
NCT05868408 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
NCT02450643 ·Status: COMPLETED ·Phase: NA
-
The Impact of Commercial Blenderized Formula on Caloric Needs, Gastrointestinal Symptoms, and Gut Microbiome in Children With Cerebral Palsy (CP)
NCT06488560 ·Status: NOT_YET_RECRUITING ·Phase: NA